PT Diagnos Laboratorium Utama Tbk
DGNS
Rank in Stocks
#26050
PT Diagnos Laboratorium Utama Tbk delivers comprehensive medical laboratory... PT Diagnos Laboratorium Utama Tbk delivers comprehensive medical laboratory services across Indonesia. The company offers a wide range of diagnostic tests, including clinical pathology services covering hematology, hemostasis, clinical chemistry, urinalysis, biomolecular analysis, immunology, and microbiology. It also performs anatomical pathology for the detailed examination of tissues and body fluids. Furthermore, PT Diagnos specializes in advanced genomics testing, such as non-invasive prenatal screening (NIPT) and preimplantation genetic testing for both aneuploidy and monogenic diseases. Beyond its core laboratory offerings, the company provides convenient home-based health check-ups, tailored corporate wellness programs, and specialized COVID-19 testing. Its broader involvement extends to supporting various healthcare initiatives and infrastructure, including maintaining specialized biological banks (e.g., eye, blood, sperm, and organ banks) and pharmacy warehousing, in collaboration with both public and private sector entities. Established in 2007, the company's headquarters are located in Jakarta Pusat, Indonesia.
Share Price
$0.01595369
Last synced: 2026-11-10
Market Cap
$21.94M
Change (1 day)
0.70%
Change (1 year)
87.76%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PT Diagnos Laboratorium Utama Tbk (DGNS)
Category
Healthcare
Operating Margin for PT Diagnos Laboratorium Utama Tbk (DGNS)
Operating Margin as of November 2026 TTM: 2.68%
According to PT Diagnos Laboratorium Utama Tbk's latest financial reports, its current operating margin (TTM) is 2.68%. At the end of 2025 the company had an operating margin of 3.05%.
Operating Margin history for PT Diagnos Laboratorium Utama Tbk from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 2.68% | -12.13% |
| 2025 | 3.05% | 124.26% |
| 2024 | 1.36% | -114.12% |
| 2023 | -9.63% | -205.25% |
| 2022 | 9.15% | -65.99% |
| 2021 | 26.90% | -26.48% |
| 2020 | 36.59% | 42.26% |
| 2019 | 25.72% | -20.27% |
| 2018 | 32.26% | 133.09% |
| 2017 | 13.84% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -93.29% |
US
|
|
| 20.38% | -92.40% |
US
|
|
| 43.02% | -83.95% |
CN
|
|
| 32.30% | -87.95% |
US
|
|
| 22.23% | -91.71% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about PT Diagnos Laboratorium Utama Tbk's operating margin
What is PT Diagnos Laboratorium Utama Tbk's operating margin?
PT Diagnos Laboratorium Utama Tbk's operating margin is 2.68%, as of Nov 2026.
What was PT Diagnos Laboratorium Utama Tbk's operating margin in 2025?
In 2025, PT Diagnos Laboratorium Utama Tbk's operating margin was 3.05%, compared with 1.36% in 2024.
How has PT Diagnos Laboratorium Utama Tbk's operating margin changed since 2020?
From 2020 to 2025, PT Diagnos Laboratorium Utama Tbk's operating margin was highest in 2020 (36.59%) and lowest in 2023 (-9.63%).
How does PT Diagnos Laboratorium Utama Tbk's operating margin compare with similar companies?
PT Diagnos Laboratorium Utama Tbk's operating margin (2.68%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.